← Back to China MedTech Export Radar · Insights
Every foreign manufacturer selling a medical device in the United States needs a U.S. Agent (21 CFR 807.40) and, in most cases, an establishment registration. Chinese manufacturers are the largest foreign group in the FDA establishment registry - and new ones enter the pipeline continuously as they register products domestically.
In this week's release of the Export Radar, 36 evidence-passed Chinese manufacturers had fresh NMPA registration activity, and 12 already hold a confirmed FDA establishment registration (openFDA match). The 12 are actively managing U.S.-market compliance; the other 24 are registering products at home and are the natural next wave of U.S. Agent candidates.
Of the 36 evidence-passed companies: 7 in Zhejiang, 6 in Guangdong, 5 in Shanghai, 4 in Jiangsu, 3 in Beijing - the classic Chinese med-device manufacturing clusters, followed by Guangxi, Hubei, Jilin, Tianjin, and Fujian. If you already work with manufacturers in one cluster, the Radar's province-level data lets you focus outreach geographically.
Rather than a generic "we offer U.S. Agent services," open with the specific registration activity you found:
"I noticed [company] filed [N] new device registration(s) with NMPA on [date]. If you're planning to export to the U.S., you'll need an establishment registration and U.S. Agent (21 CFR 807) - happy to walk you through what that involves."
Specificity beats volume every time - and it is exactly what the Export Radar is built to provide.
Want the shortlist instead of the manual work? Start with 5 companies at USD 49 or 10 at USD 99. Larger packs remain available at USD 369 and USD 599. Every tier includes business emails, official websites, registration references, confidence grades, and a suggested outreach angle.
See the packs Download the 3-company sample (XLSX)